Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
![Noteworthy comment: The paper is well written and will contribute greatly to the present understanding and clinical application of new biologics in the treatment of psoriasis.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,619 | Dovepress* | 7,366+ | 1,260 | 8,626 | |
PubMed Central* | 3,253 | 511 | 3,764 | ||
Totals | 10,619 | 1,771 | 12,390 | ||
*Since 18 June 2019 |
View citations on PubMed Central and Google Scholar